G Medical
(ASX:GMV) has signed an exclusive agreement to distribute its medical products to the Cyprus and Greece markets in collaboration with MEDTL Medical Technologies.
The deal comprises an initial commitment of US$10.5 million of the Prizma Medical smartphone cases.
This news comes after the FDA and CE approved distribution of the product in Europe and the US.
MEDTL will distribute the Prizma cases and will collaborate with G Medical to deliver a 24/7 medical call centre service.
The smartphone service will enable medical monitoring from the consumer’s mobile phone and store medical data to enable sharing with healthcare professionals.
Shares in G Medical
(ASX:GMV) are trading 3.49 lower to 42 cents a share.
